Aperimus Capital’s Cintas CTAS Stock Holding History

Aperimus Capital’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-88,000	Closed	-$3.81M	–	4
2020 Q1	$3.81M	Buy	+88,000	New	+$5.75M	2.48%	4

Other funds holding CTAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Aperimus Capital's CTAS Position: Q2 2020 in Review

Aperimus Capital sold out of Cintas (CTAS) in Q2 2020, closing a stake of 88,000 shares — an estimated $3.81M sold.

Aperimus Capital first reported a position in CTAS in Q1 2020 and held it in 1 quarter. The position peaked at $3.81M in Q1 2020. 760 funds tracked by Wall St. Rank hold CTAS as of Q2 2020.

Aperimus Capital reported no remaining Cintas position as of Q2 2020 after selling out during the quarter.
Aperimus Capital sold 88,000 Cintas shares in Q2 2020, an estimated $3.81M.
Aperimus Capital first reported a position in Cintas in Q1 2020 and held it in 1 quarter.
Aperimus Capital's Cintas position peaked at $3.81M in Q1 2020.
760 funds tracked by Wall St. Rank held Cintas as of Q2 2020.

Based on Aperimus Capital's 13F filing for Q2 2020, filed 22 Jul 2020.